ISTANBUL — BioNTech SE Chief Executive Ugur Sahin said Thursday the COVID-19 vaccine it developed with Pfizer Inc is expected to be 70% to 75% effective in protecting against infections caused by the coronavirus variant first detected in India.
“So far we’ve had the chance to test our vaccine against more than 30 variants of the virus. It has proven effective against mutations so far,” said Sahin, a German scientist with Turkish parents, speaking Turkish in televised comments.
Tests this week have focused on the India variant, he said. “We expect (our vaccine) to protect against infections by 70% to 75%,” he said after virtually attending the Turkish government’s science coun…
Keep on reading: BioNTech CEO says vaccine up to 75% effective against India variant